Work

Targeting survivin via PI3K but not c-akt/PKB by anticancer drugs in immature neutrophils

Year: 2006

Type: article

Source: Oncogene

DOI: 10.1038/sj.onc.1209692

Authors: S Martinelli, G Kostylina, V Niggli, C Baumann, M F Fey, H-G Wendel, S W Lowe, S Yousefi, H-U Simon

Institutions: University of Bern, University Hospital of Bern, Cold Spring Harbor Laboratory

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Bristol-Myers Squibb, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

OpenAlex ID: W2009631348

FWCI: 1.227

Cites: 48

Cited by: 18

Related to: 10